Search Results - "ZENT, C. S"

A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation by Lipof, J. J., Huselton, E. J., Zent, C. S., Evans, A., Zhang, B., Rothberg, P. G., Bennett, J. M.

“…Acute eosinophilic leukemia (AEL) is a rare form of acute myeloid leukemia (AML) that requires prompt exclusion of reactive etiologies of eosinophilia and…”
Get full text

Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population by Shanafelt, T D, Kay, N E, Rabe, K G, Call, T G, Zent, C S, Schwager, S M, Leis, J F, Jelinek, D F, Slager, S L, Hanson, C A

Get full text

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients by Mato, A.R., Hill, B.T., Lamanna, N., Barr, P.M., Ujjani, C.S., Brander, D.M., Howlett, C., Skarbnik, A.P., Cheson, B.D., Zent, C.S., Pu, J.J., Kiselev, P., Foon, K., Lenhart, J., Henick Bachow, S., Winter, A.M., Cruz, A.-L., Claxton, D.F., Goy, A., Daniel, C., Isaac, K., Kennard, K.H., Timlin, C., Fanning, M., Gashonia, L., Yacur, M., Svoboda, J., Schuster, S.J., Nabhan, C.

“…Ibrutinib, idelalisib, and venetoclax are approved for treating CLL patients in the United States. However, there is no guidance as to their optimal sequence…”
Get full text

Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia by Nowakowski, G. S., Dewald, G. W., Hoyer, J. D., Paternoster, S. F., Stockero, K. J., Fink, S. R., Smoley, S. A., Remstein, E. D., Phyliky, R. L., Call, T. G., Shanafelt, T. D., Kay, N. E., Zent, C. S.

“…Summary Translocations involving IGH are common in some lymphoid malignancies but are believed to be rare in chronic lymphocytic leukaemia (CLL). To study the…”
Get full text

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies by Shanafelt, T.D., Lee, Y.K., Call, T.G., Nowakowski, G.S., Dingli, D., Zent, C.S., Kay, N.E.

“…Green tea or its constituents have long been touted as a health promoting substance including claims it may have cancer prevention properties. We previously…”
Get full text

Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation by ZENT, C. S, WILSON, C. S, TRICOT, G, JAGANNATH, S, SIEGEL, D, DESIKAN, K. R, MUNSHI, N, BRACY, D, BARLOGIE, B, BUTCH, A. W

“…Multiple myeloma (MM) is usually characterized by production of a single serum monoclonal protein of constant isotype and light-chain restriction. Multiple Ig…”
Get full text

Anti‐CD20 monoclonal antibody‐dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages by Church, A. K., VanDerMeid, K. R., Baig, N. A., Baran, A. M., Witzig, T. E., Nowakowski, G. S., Zent, C. S.

“…Summary Unconjugated monoclonal antibodies (mAbs) are an important component of effective combination therapies for chronic lymphocytic leukaemia (CLL)…”
Get full text

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia by Murphy, E J, Neuberg, D S, Rassenti, L Z, Hayes, G, Redd, R, Emson, C, Li, K, Brown, J R, Wierda, W G, Turner, S, Greaves, A W, Zent, C S, Byrd, J C, McConnel, C, Barrientos, J, Kay, N, Hellerstein, M K, Chiorazzi, N, Kipps, T J, Rai, K R

“…The clinical course of patients with recently diagnosed early stage chronic lymphocytic leukemia (CLL) is highly variable. We examined the relationship between…”
Get full text

Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer by Kohli, M, Fink, L M, Spencer, H J, Zent, C S

“…Cancer and increased age are risk factors for coagulation activation. Patients with advanced prostate cancer, which usually presents in the seventh to eighth…”
Get full text

Factor XII Deficiency Acquired by Orthotopic Liver Transplantation: Case Report and Review of the Literature by Osborn, N. K., Ustundag, Y., Zent, C. S., Wiesner, R. H., Rosen, C. B., Narayanan Menon, K. V.

“…Transmission of congenital clotting factor deficiencies after orthotopic liver transplantation is rare. There are published reports of liver donor‐to‐recipient…”
Get full text

Linezolid-Induced Pure Red Blood Cell Aplasia by Monson, Thomas, Schichman, Steven A., Zent, Clive S.

“…We report a case of reversible pure red blood cell aplasia that developed in a patient who had received 8 weeks of linezolid therapy…”
Get full text

The Chimeric Genes AML1/MDS1 and AML1/EAP Inhibit AML1B Activation at the CSF1R Promoter, but Only AML1/MDS1 has Tumor-Promoter Properties by Zent, Clive S., Mathieu, Carol, Claxton, David F., Zhang, Dong-Er, Tenen, Daniel G., Rowley, Janet D., Nucifora, Giuseppina

“…The (3;21) (q26;q22) translocation associated with treatment-related myelodysplastic syndrome, treatment-related acute myeloid leukemia, and blast crisis of…”
Get full text

Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data by Zent, Clive S., Kyasa, Mouhammed J., Evans, Richard, Schichman, Steven A.

“…BACKGROUND Although chronic lymphocytic leukemia (CLL) often is described as the most common leukemia in the U.S. and Western Europe, to the authors' knowledge…”
Get full text

Use of HFE mutation analysis for hereditary hemochromatosis : The need for physician education in the translation of basic science to clinical practice by KOHLI, M, SCHICHMAN, S. A, FINK, L, ZENT, C. S

“…Hereditary hemochromatosis (HH) is a common hereditary disorder of iron metabolism causing iron overload, organ failure, and malignancy. Preclinical diagnosis…”
Get full text

Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium by Zent, Clive S., Chen, James B., Kurten, Richard C., Kaushal, Gur P., Marie Lacy, H., Schichman, Steven A.

“…The mechanism of action of alemtuzumab (CAMPATH 1H) in chronic lymphocytic leukemia (CLL) is uncertain. We tested the hypothesis that alemtuzumab alone can…”
Get full text

Prediction of amikacin dose requirements in neutropenic patients with haematological disease by ZENT, C. S, ALLIN, R, FOLB, P. I

“…This study reports on the use of an easily applied Bayesian forecasting programme (OPT; Clydesoft) to predict amikacin dose requirements in 10 patients with…”
Get full text

Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura by Zent, Clive S., Ratajczak, Janina, Ratajczak, Mariusz Z., Anastasi, John, Hoffman, Philip C., Gewirtz, Alan M.

“…Cyclic amegakaryocytic thrombocytopenic purpura is a rare syndrome characterized by periodic failure of megakaryocytopoiesis. In this report we describe a…”
Get full text

The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype by Zent, Clive S, Zhan, Fenghuang, Schichman, Steven A, Bumm, Klaus H.W, Lin, Pei, Chen, James B, Shaughnessy, John D

“…We compared gene expression in purified tumor cells from untreated patients with chronic lymphocytic (CLL) ( n=24) and newly diagnosed multiple myeloma (MM) (…”
Get full text

Localized herpes simplex lymphadenitis mimicking large‐cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma by Joseph, Lija, Scott, Margie A., Schichman, Steven A., Zent, Clive S.

“…We report a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who presented with rapid enlargement of a cervical lymph node due to…”
Get full text

Phase II trial of daily, oral green tea extract in patients with asymptomatic, Rai stage 0-II chronic lymphocytic leukemia (CLL) by Shanafelt, T. D., Call, T., Zent, C. S., LaPlant, B., Leis, J. F., Bowen, D., Roos, M., Jelinek, D. F., Erlichman, C., Kay, N. E.

“…Abstract only…”
Get full text